| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |